DE69405198D1 - 1,3,4-Oxadiazol-2(3H)-one-Derivate, ihre Herstellung und ihre Verwendung als Monoaminoxidase-Hemmer - Google Patents

1,3,4-Oxadiazol-2(3H)-one-Derivate, ihre Herstellung und ihre Verwendung als Monoaminoxidase-Hemmer

Info

Publication number
DE69405198D1
DE69405198D1 DE69405198T DE69405198T DE69405198D1 DE 69405198 D1 DE69405198 D1 DE 69405198D1 DE 69405198 T DE69405198 T DE 69405198T DE 69405198 T DE69405198 T DE 69405198T DE 69405198 D1 DE69405198 D1 DE 69405198D1
Authority
DE
Germany
Prior art keywords
group
oxadiazol
alkoxy
derivatives
monoamine oxidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69405198T
Other languages
English (en)
Other versions
DE69405198T2 (de
Inventor
Jean-Jacques Koenig
Samir Jegham
Frederic Puech
Philippe Burnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of DE69405198D1 publication Critical patent/DE69405198D1/de
Application granted granted Critical
Publication of DE69405198T2 publication Critical patent/DE69405198T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69405198T 1993-11-26 1994-11-21 1,3,4-Oxadiazol-2(3H)-one-Derivate, ihre Herstellung und ihre Verwendung als Monoaminoxidase-Hemmer Expired - Fee Related DE69405198T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9314151A FR2712886B1 (fr) 1993-11-26 1993-11-26 Dérivés de 1,3,4-oxadiazol-2(3H)-one, leur préparation et leur application en thérapeutique.

Publications (2)

Publication Number Publication Date
DE69405198D1 true DE69405198D1 (de) 1997-10-02
DE69405198T2 DE69405198T2 (de) 1998-01-29

Family

ID=9453245

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69405198T Expired - Fee Related DE69405198T2 (de) 1993-11-26 1994-11-21 1,3,4-Oxadiazol-2(3H)-one-Derivate, ihre Herstellung und ihre Verwendung als Monoaminoxidase-Hemmer

Country Status (24)

Country Link
US (1) US5525619A (de)
EP (1) EP0655445B1 (de)
JP (1) JPH07196636A (de)
KR (1) KR950014088A (de)
CN (1) CN1106395A (de)
AT (1) ATE157356T1 (de)
AU (1) AU679127B2 (de)
CA (1) CA2136669A1 (de)
CZ (1) CZ291794A3 (de)
DE (1) DE69405198T2 (de)
DK (1) DK0655445T3 (de)
ES (1) ES2107157T3 (de)
FI (1) FI945562A (de)
FR (1) FR2712886B1 (de)
GR (1) GR3025272T3 (de)
HU (1) HUT71111A (de)
IL (1) IL111769A (de)
NO (1) NO944513L (de)
NZ (1) NZ264991A (de)
PL (1) PL305999A1 (de)
RU (1) RU94042230A (de)
SK (1) SK143594A3 (de)
TW (1) TW284761B (de)
ZA (1) ZA949394B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763068B1 (fr) * 1997-05-06 1999-06-04 Synthelabo Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2766485B1 (fr) * 1997-07-23 2002-05-24 Synthelabo Derives de 2,4-dihydro-3h-1,2,4-triazol-3-one, leur prparation et leur application en therapeutique
JP2001039954A (ja) * 1999-05-24 2001-02-13 Tomono Agrica Co Ltd ヘテロ環誘導体
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
CN104016938B (zh) * 2014-05-28 2016-08-17 浙江工业大学 一种含苯硒基的噁二唑类化合物及其制备与应用
CN104016939B (zh) * 2014-05-28 2016-06-15 浙江工业大学 一种2-亚乙基-3-乙酰基-1,3,4-噁二唑类化合物及其制备与应用
GB201814151D0 (en) 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631827B1 (fr) * 1988-05-27 1992-03-27 Delalande Sa Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique
JPH0366056A (ja) * 1989-08-03 1991-03-20 Matsushita Electric Ind Co Ltd 回転ヘッド装置
FR2655044B1 (fr) * 1989-11-24 1995-03-03 Delalande Sa Derives d'(hetero) arylmethyloxy-4 phenyl tetrazole et oxadiazole, leur procede de preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
FR2712886A1 (fr) 1995-06-02
KR950014088A (ko) 1995-06-15
EP0655445B1 (de) 1997-08-27
CN1106395A (zh) 1995-08-09
JPH07196636A (ja) 1995-08-01
AU679127B2 (en) 1997-06-19
FI945562A0 (fi) 1994-11-25
IL111769A (en) 1999-04-11
CZ291794A3 (en) 1995-07-12
PL305999A1 (en) 1995-05-29
NO944513L (no) 1995-05-29
FR2712886B1 (fr) 1996-01-05
IL111769A0 (en) 1995-01-24
ATE157356T1 (de) 1997-09-15
NZ264991A (en) 1995-07-26
HUT71111A (en) 1995-11-28
DE69405198T2 (de) 1998-01-29
DK0655445T3 (da) 1998-03-23
FI945562A (fi) 1995-05-27
RU94042230A (ru) 1996-11-20
HU9403393D0 (en) 1995-02-28
ZA949394B (en) 1995-09-07
NO944513D0 (no) 1994-11-25
US5525619A (en) 1996-06-11
AU7903094A (en) 1995-06-01
EP0655445A1 (de) 1995-05-31
TW284761B (de) 1996-09-01
CA2136669A1 (en) 1995-05-27
SK143594A3 (en) 1995-06-07
ES2107157T3 (es) 1997-11-16
GR3025272T3 (en) 1998-02-27

Similar Documents

Publication Publication Date Title
ES486349A1 (es) Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas
DE122009000040I2 (de) Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
AU7503087A (en) Amide derivatives
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
EP0632031A4 (de)
HUP0100470A2 (hu) Oxazolidinonszármazékok és ilyen vegyületeket tartalmazó gyógyászati készítmények
DE69405198D1 (de) 1,3,4-Oxadiazol-2(3H)-one-Derivate, ihre Herstellung und ihre Verwendung als Monoaminoxidase-Hemmer
ES2037665T3 (es) Procedimiento para la preparacion de compuestos heterociclicos que contienen n.
ES2119106T3 (es) Nuevos benzo-espiro-alquenos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
GR3034023T3 (en) Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them.
ATE100077T1 (de) 2-hydroxy-3-phenoxypropylaminoverbindungen.
AR009452A1 (es) Compuestos de dihalopropeno, los agentes insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos.
ES2124379T3 (es) Nuevos benzo-espiro-alquenos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE60000880D1 (de) Fluorierte benzodioxan imidazolin derivate, deren herstellung und deren therapeutische verwendung
ES2101910T3 (es) Composicion para acelerar la curacion de heridas.
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
GR3002594T3 (en) Aromatic thioethers
HUT42280A (en) Fungicidal compositions and process for preparing piperazinyl-methyl-1,2,4-triazolyl-methyl-carbinol derivatives applicable as active substance
ES2043631T3 (es) Procedimiento de preparacion de hidroxialquilxantinas.
DE69105108D1 (de) Substituierte N-[Phenyl-(thioxomethyl)]-morpholinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Zusammensetzung und ihre Verwendung.
ES2107376A1 (es) Nuevos derivados de pirimidona con actividad antifungica.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

8339 Ceased/non-payment of the annual fee